Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 13-Dec-17 4:42 PM View:  | Tranzyme, Inc. (OCRX) | 11-Dec-17 | Disposition | 1,857,040 | -- | -- | (100%) 1.86M to 0 | |
| 03-Nov-16 9:42 PM View: | Tobira Therapeutics, Inc. (TBRA) | 01-Nov-16 | Disposition (change in control) | 285,679 | $28.35 | $8,099,000.00 | (100%) 285.68K to 0 | |
| 13-Sep-16 4:27 PM View: | Colucid Pharmaceuticals, Inc. (CLCD) | 09-Sep-16 | Disposition (other) | 1,943,110 | -- | -- | (100%) 1.94M to 0 | |
| 03-Aug-16 6:08 PM View: | Colucid Pharmaceuticals, Inc. (CLCD) | 03-Aug-16 | Market Sale | 81,094 | $8.15 | $660,916.00 | (4%) 2.02M to 1.94M | (411%) |
| 03-Aug-16 6:08 PM View: | Colucid Pharmaceuticals, Inc. (CLCD) | 02-Aug-16 | Market Sale | 19,718 | $8.71 | $171,744.00 | (< 1%) 2.04M to 2.02M | (378%) |
| 03-Aug-16 6:08 PM View: | Colucid Pharmaceuticals, Inc. (CLCD) | 01-Aug-16 | Market Sale | 52,216 | $8.82 | $460,545.00 | (2%) 2.1M to 2.04M | (372%) |
| 02-May-16 4:54 PM View: | Colucid Pharmaceuticals, Inc. (CLCD) | 28-Apr-16 | Market Sale | 149,765 | $6.96 | $1,042,360.00 | (7%) 2.25M to 2.1M | (499%) |
| 08-Mar-16 11:47 AM View: | Syndax Pharmaceuticals Inc (SNDX) | 08-Mar-16 | Conversion | 1,743,850 | -- | -- | 100% 0 to 1.74M | |
| 11-May-15 4:03 PM View: | Colucid Pharmaceuticals, Inc. (CLCD) | 11-May-15 | Conversion | 2,202,230 | -- | -- | 5043% 43.67K to 2.25M | |
| 07-Aug-14 3:06 PM View: | Marinus Pharmaceuticals, Inc. (MRNS) | 05-Aug-14 | Conversion | 2,057,140 | -- | -- | 100% 0 to 2.06M | |
| 07-Aug-14 3:06 PM View: | Marinus Pharmaceuticals, Inc. (MRNS) | 05-Aug-14 | Market Purchase | 419,744 | $8.00 | $3,357,950.00 | 20% 2.06M to 2.48M | (63%) |
| 07-May-14 2:55 PM View: | Aldeyra Therapeutics, Inc. (ALDX) | 07-May-14 | Conversion | 21,250 | -- | -- | 1% 1.95M to 1.97M | |
| 05-May-14 11:41 AM View: | Aldeyra Therapeutics, Inc. (ALDX) | 01-May-14 | Conversion | 1,909,110 | -- | -- | 100% 0 to 1.91M | |
| 05-May-14 11:41 AM View: | Aldeyra Therapeutics, Inc. (ALDX) | 01-May-14 | Payment of Exercise | 78,126 | $8.00 | $625,008.00 | (4%) 2.03M to 1.95M | |
| 05-May-14 11:41 AM View: | Aldeyra Therapeutics, Inc. (ALDX) | 01-May-14 | Option Exercise | 121,152 | $5.16 | $625,144.00 | 6% 1.91M to 2.03M | |
| 21-Mar-14 7:24 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 19-Mar-14 | Disposition | 7,313,240 | $14.00 | $102,385,000.00 | (100%) 7.31M to 0 | < 1% |
| 17-Jan-14 4:19 PM View: | Alimera Sciences Inc (ALIM) | 16-Jan-14 | Market Sale (Planned) | 204,315 | $6.56 | $1,340,310.00 | (5%) 3.8M to 3.59M | 95% |
| 17-Jan-14 4:19 PM View: | Alimera Sciences Inc (ALIM) | 15-Jan-14 | Market Sale (Planned) | 92,445 | $6.01 | $555,594.00 | (2%) 3.89M to 3.8M | 95% |
| 28-Aug-13 11:43 AM View: | Tobira Therapeutics, Inc. (TBRA) | 27-Aug-13 | Conversion | 1,785,570 | -- | -- | 5023% 35.55K to 1.82M | |
| 28-Aug-13 11:43 AM View: | Tobira Therapeutics, Inc. (TBRA) | 27-Aug-13 | Purchase | 750,000 | $4.00 | $3,000,000.00 | 41% 1.82M to 2.57M | |
| 16-Jul-13 8:41 PM View: | Tranzyme, Inc. (OCRX) | 15-Jul-13 | Purchase | 331,873 | $6.03 | $2,000,000.00 | 21% 1.57M to 1.9M | |
| 24-Jun-13 4:25 PM View: | Alimera Sciences Inc (ALIM) | 20-Jun-13 | Market Sale (Planned) | 10,516 | $5.01 | $52,685.20 | (< 1%) 3.9M to 3.89M | 94% |
| 20-Jun-13 5:12 PM View: | Alimera Sciences Inc (ALIM) | 19-Jun-13 | Market Sale (Planned) | 22,423 | $5.37 | $120,412.00 | (< 1%) 3.92M to 3.9M | 94% |
| 20-Jun-13 5:12 PM View: | Alimera Sciences Inc (ALIM) | 18-Jun-13 | Market Sale (Planned) | 32,855 | $5.40 | $177,417.00 | (< 1%) 3.95M to 3.92M | 95% |
| 18-Jun-13 5:06 PM View: | Alimera Sciences Inc (ALIM) | 17-Jun-13 | Market Sale (Planned) | 87,812 | $5.40 | $474,185.00 | (2%) 4.04M to 3.95M | 95% |
| 18-Jun-13 5:06 PM View: | Alimera Sciences Inc (ALIM) | 14-Jun-13 | Market Sale (Planned) | 38,897 | $5.03 | $195,652.00 | (< 1%) 4.08M to 4.04M | 94% |
| 13-Jun-13 4:56 PM View: | Alimera Sciences Inc (ALIM) | 11-Jun-13 | Market Sale (Planned) | 5,337 | $5.00 | $26,685.00 | (< 1%) 4.09M to 4.08M | 94% |
| 17-May-13 5:32 PM View: | Alimera Sciences Inc (ALIM) | 16-May-13 | Market Sale | 21,276 | $4.50 | $95,742.00 | (< 1%) 4.11M to 4.09M | 93% |
| 17-May-13 5:32 PM View: | Alimera Sciences Inc (ALIM) | 15-May-13 | Market Sale | 22,966 | $4.70 | $107,940.00 | (< 1%) 4.13M to 4.11M | 94% |
| 17-Apr-13 5:14 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 15-Apr-13 | Market Sale (Planned) | 71,578 | $6.62 | $473,846.00 | (< 1%) 7.38M to 7.31M | (19%) |
| 10-Apr-13 4:47 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 10-Apr-13 | Market Sale (Planned) | 4,832 | $6.72 | $32,471.00 | (< 1%) 7.39M to 7.38M | (17%) |
| 10-Apr-13 4:47 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 09-Apr-13 | Market Sale (Planned) | 35,114 | $6.71 | $235,615.00 | (< 1%) 7.42M to 7.39M | (17%) |
| 10-Apr-13 4:47 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 08-Apr-13 | Market Sale (Planned) | 37,676 | $6.52 | $245,648.00 | (< 1%) 7.46M to 7.42M | (21%) |
| 22-Mar-13 8:22 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 21-Mar-13 | Market Sale (Planned) | 13,490 | $5.35 | $72,171.50 | (< 1%) 7.48M to 7.46M | (47%) |
| 21-Mar-13 5:02 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 20-Mar-13 | Market Sale (Planned) | 16,995 | $5.22 | $88,713.90 | (< 1%) 7.49M to 7.48M | (51%) |
| 21-Mar-13 5:02 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 19-Mar-13 | Market Sale (Planned) | 24,442 | $5.19 | $126,854.00 | (< 1%) 7.52M to 7.49M | (52%) |
| 19-Mar-13 4:39 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 18-Mar-13 | Market Sale (Planned) | 24,736 | $5.16 | $127,638.00 | (< 1%) 7.54M to 7.52M | (53%) |
| 19-Mar-13 4:39 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 15-Mar-13 | Market Sale (Planned) | 29,719 | $5.28 | $156,916.00 | (< 1%) 7.57M to 7.54M | (49%) |
| 15-Mar-13 4:57 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 14-Mar-13 | Market Sale (Planned) | 15,480 | $5.36 | $82,972.80 | (< 1%) 7.59M to 7.57M | (47%) |
| 15-Mar-13 4:57 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 13-Mar-13 | Market Sale (Planned) | 23,848 | $5.40 | $128,779.00 | (< 1%) 7.61M to 7.59M | (46%) |
| 13-Mar-13 8:36 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 12-Mar-13 | Market Sale (Planned) | 19,569 | $5.38 | $105,281.00 | (< 1%) 7.63M to 7.61M | (46%) |
| 13-Mar-13 8:36 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 11-Mar-13 | Market Sale (Planned) | 12,700 | $5.34 | $67,818.00 | (< 1%) 7.64M to 7.63M | (48%) |
| 11-Mar-13 6:32 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 08-Mar-13 | Market Sale (Planned) | 15,892 | $5.32 | $84,545.40 | (< 1%) 7.66M to 7.64M | (48%) |
| 11-Mar-13 6:32 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 07-Mar-13 | Market Sale (Planned) | 39,168 | $5.22 | $204,457.00 | (< 1%) 7.7M to 7.66M | (51%) |
| 07-Mar-13 6:22 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 06-Mar-13 | Market Sale (Planned) | 11,841 | $5.06 | $59,915.50 | (< 1%) 7.71M to 7.7M | (56%) |
| 07-Mar-13 6:22 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 05-Mar-13 | Market Sale (Planned) | 12,454 | $5.01 | $62,394.50 | (< 1%) 7.72M to 7.71M | (57%) |
| 05-Mar-13 5:02 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 04-Mar-13 | Market Sale (Planned) | 15,865 | $5.01 | $79,483.70 | (< 1%) 7.74M to 7.72M | (57%) |
| 05-Mar-13 5:02 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 01-Mar-13 | Market Sale (Planned) | 23,548 | $5.01 | $117,975.00 | (< 1%) 7.76M to 7.74M | (57%) |
| 22-Feb-13 4:58 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 20-Feb-13 | Market Sale (Planned) | 6,160 | $5.01 | $30,861.60 | (< 1%) 7.77M to 7.76M | (57%) |
| 20-Feb-13 4:43 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 19-Feb-13 | Market Sale (Planned) | 31,075 | $5.02 | $155,996.00 | (< 1%) 7.8M to 7.77M | (57%) |